Chemoenzymatic Synthesis of the New 3-((2,3-Diacetoxypropanoyl)oxy)propane-1,2-diyl Diacetate Using Immobilized Lipase B from Candida antarctica and Pyridinium Chlorochromate as an Oxidizing Agent

• Published in: International Journal of Molecular Sciences
• Main Authors: Plata, Esteban, Ruiz, Mónica, Ruiz, Jennifer, Ortiz, Claudia, Castillo, John J., Fernández-Lafuente, Roberto
• Other Authors: Colciencias (Colombia), Universidad Industrial de Santander (Colombia), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España)
• Format: Article in Journal/Newspaper
• Language: English
• Published: Multidisciplinary Digital Publishing Institute 2020
• Subjects: Chemoenzymatic synthesis; Glycerol derivatives; Interfacially activated lipase; Regioselective hydrolysis; Diacetin oxidation; Pyridinium chlorochromate; Antibacterial activity; Antifungal activity; Hemolytic activity; Antarc*; Antarctica
• Online Access: http://hdl.handle.net/10261/220355; https://doi.org/10.3390/ijms21186501; https://doi.org/10.13039/501100011033; https://doi.org/10.13039/501100009087

© 2020 by the authors. To exploit the hydrolytic activity and high selectivity of immobilized lipase B from Candida antarctica on octyl agarose (CALB-OC) in the hydrolysis of triacetin and also to produce new value-added compounds from glycerol, this work describes a chemoenzymatic methodology for the synthesis of the new dimeric glycerol ester 3-((2,3-diacetoxypropanoyl)oxy)propane-1,2-diyl diacetate. According to this approach, triacetin was regioselectively hydrolyzed to 1,2-diacetin with CALB-OC. The diglyceride product was subsequently oxidized with pyridinium chlorochromate (PCC) and a dimeric ester was isolated as the only product. It was found that the medium acidity during the PCC treatment and a high 1,2-diacetin concentration favored the formation of the ester. The synthesized compounds were characterized using IR, MS, HR-MS, and NMR techniques. The obtained dimeric ester was evaluated at 100 ppm against seven bacterial strains and two Candida species to identify its antimicrobial activity. The compound has no inhibitory activity against the bacterial strains used but decreased C. albicans and C. parapsilosis growth by 49% and 68%, respectively. Hemolytic activity was evaluated, and the results obtained support the use of the dimeric ester to control C. albicans and C. parapsilosis growth in non-intravenous applications because the compound shows hemolytic activity. This research was funded by Colciencias, project number FP 44842-076-2016, and Universidad Industrial de Santander (Vicerrectoría de Investigación y Extension, project number 8854) and Spanish Ministerio de Ciencia e Innovación, grant number CTQ2017-86170-R. Peer reviewed